Status:
RECRUITING
18F-Fluorocholine Positron Emission Tomography (PET) for the Detection of Parathyroid Adenomas
Lead Sponsor:
Thomas Hope
Conditions:
Hyperparathyroidism, Primary
Eligibility:
All Genders
13+ years
Phase:
PHASE3
Brief Summary
This is a prospective single arm single center Phase III study evaluating the ability of 18F-fluorocholine to detect the location of parathyroid adenomas.
Detailed Description
PRIMARY OBJECTIVE: I. To investigate the performance (accuracy) of 18F-fluorocholine PET in the detection of hyperfunctioning parathyroid glands in surgical patients with biochemically proven primary...
Eligibility Criteria
Inclusion
- Age \>= 13 years.
- Biochemically proven hyperparathyroidism and an indication for surgery.
- Ability to understand a written informed consent document, and the willingness to sign it.
Exclusion
- Current Pregnancy.
- Patients unlikely to comply with study procedures, restrictions and requirements and judged by the Investigator to be unsuitable for study participation.
Key Trial Info
Start Date :
June 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2027
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT04895631
Start Date
June 30 2021
End Date
June 30 2027
Last Update
December 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94107